Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Resistance news

Show

From To
Transmitted HIV Resistance Rate Close to 20% in Large Study of US MSM

More than 17% of antiretroviral-naive men who have sex with men (MSM) in a large US study carried antiretroviral-resistant virus, according to a nationwide analysis by the Centers for Disease Control and Prevention (CDC)]. MSM under 30 years old had close to a 19% prevalence of transmitted resistant HIV.

Published
06 March 2014
From
NATAP
Average CD4 cell count at time HIV therapy was started increased among young people in New York City after 2009

The average CD4 cell count at which young people living with HIV in New York City started antiretroviral therapy increased significantly after US guidelines changed in late

Published
29 January 2014
By
Michael Carter
Successful HIV drug resistance testing is possible when viral load is low

HIV drug resistance testing can perform well, even when viral load is as low as 250 copies/ml, results of two studies published in the online edition of

Published
27 January 2014
By
Michael Carter
Janssen to Stop Offering "Virtual Phenotype" Testing, and Musings on Progress

As is plainly obvious to anyone doing HIV care, the incidence of new patients with the sort of HIV drug resistance for which the test was developed has plummeted. There simply aren't many new patients out there who have multiple mutations, especially in the PI-drug class, and who will need the computational black-box firepower provided by a vircoTYPE.

Published
27 November 2013
From
The BodyPRO
People who aren't taking HIV treatment are a major source of transmitted resistance in Swiss gay men

Individuals who have never taken antiretroviral therapy (ART) are the main source of transmitted HIV drug resistance among gay men, Swiss research published in the online edition of

Published
21 November 2013
By
Michael Carter
HIV may be becoming less fit as it adapts to the immune system

HIV, at least in some parts of the world, may be developing a lower replicative capacity as it adapts to variations in the human immune system, studies

Published
08 November 2013
By
Gus Cairns
Number of people infected with drug-resistant HIV in Europe has risen by around 35%

The number of people in Europe who have become infected with a drug-resistant strain of HIV may have increased by around 35% since 2003, even though the

Published
17 October 2013
By
Keith Alcorn
Big differences in virological outcomes among people taking first-line HIV therapy in resource-limited settings

Virological outcomes vary enormously among people taking antiretroviral therapy in different resource-limited settings, according to research published in the online edition of Clinical Infectious Diseases. An international team of

Published
16 October 2013
By
Michael Carter
Persisently detectable viral load at any level increases risk of HIV treatment failure

For people taking HIV therapy, a persistent detectable viral load at any level is associated with an increased risk of virologic failure, Canadian research published in the online

Published
29 August 2013
By
Michael Carter
Licensing agreement for development of diagnostic tests for HIV drug resistance

An exclusive worldwide licensing agreement has been signed for the rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus (HIV). The tests will be used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and the ability of the virus to infect different cells within the patient. The HIV assays also can be used by academic and corporate researchers to develop novel strategies to block HIV replication.

Published
03 July 2013
From
University Hospitals Case Medical Center
← First12345...29Next →

Filter by country